Ornithine Transcarbamylase (OTC) Deficiency Treatment Top Companies

  1. Amgen

  2. Ultragenyx Pharmaceutical Inc.

  3. Zevra Therapeutics

  4. Bausch Health

  5. Danone Group

*Disclaimer: Top companies sorted in no particular order

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Major Players

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Concentration

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Concentration

Ornithine Transcarbamylase (OTC) Deficiency Treatment Company List

  • Amgen

  • Bausch Health

  • Ultragenyx Pharmaceutical Inc.

  • Zevra Therapeutics

  • Arcturus Therapeutics Inc.

  • iECURE

  • Danone Group (Nutricia)

  • Abbott Laboratories

  • Nestlé Health Science

  • Reckitt Benckiser Group

  • Moderna

  • Eurocept (Lucane Pharma)

  • UniQure N.V.

  • Astellas Gene Therapies

  • AstraZeneca

  • Asklepios BioPharmaceutical

  • Generation Bio

  • OrphanPacific Inc.

  • Immedica Pharma AB

Need More Details on Market Players and Competitors?
Download PDF

Ornithine Transcarbamylase (OTC) Deficiency Treatment Report Snapshots